eighteen of 25 ( 72 % ) treated by sequential estrogen and irradiation , 14/17 ( 82 % ) with estrogen responsive cancer and 4/8 ( 50 % ) with estrogen resistant cancer had a complete tumor response .
C0006826
cancer
C0027651
tumor